https://www.businesswire.com/news/home/20260422702864/en/Vyome-Presents-Transformational-VT-1953-Phase-2-Clinical-Study-Data-at-Prestigious-AACR-2026
Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
https://markets.businessinsider.com/news/hind-stock
Vyome Holdings News | Markets Insider
Vyome Holdings News: This is the News-site for the company Vyome Holdings on Markets Insider
holdingsnewsmarketsinsider
https://www.businesswire.com/news/home/20251208813165/en/Vyome-Reports-Positive-Final-Phase-2-Results-for-VT-1953-Plans-to-Advance-Into-Pivotal-Study-For-FDA-Approval
Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For...
Vyome VT-1953 P2 results
https://markets.businessinsider.com/news/stocks/vyome-holdings-publishes-preclinical-vt-1908-data-1035842181
Vyome Holdings publishes preclinical VT-1908 data | Markets Insider
Vyome Holdings (HIND) announced the publication of its preclinical data validating the efficacy and safety of VT-1908 as a potential treatment f...
data marketsholdingspublishespreclinicalvt